Wu X - Search Results

1

Plasma metabolomic signatures from patients following high-dose total body irradiation.

Hong X, Tian L, Wu Q, Gu L, Wang W, Wu H, Zhao M, Wu X, Wang C. Hong X, et al. Among authors: wu h, wu x, wu q. Mol Omics. 2023 Jul 10;19(6):492-503. doi: 10.1039/d2mo00274d. Mol Omics. 2023. PMID: 37098727

2

[Metabolomics of Chronic Myelogenous Leukemia Based on GC-MS].

Yang BY, Li XL, Yao Y, Wang C, Chen SN, Wu XJ, Wu DP. Yang BY, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Dec;25(6):1585-1591. doi: 10.7534/j.issn.1009-2137.2017.06.001. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017. PMID: 29262880 Chinese.

3

Monitoring tyrosine kinase inhibitor therapeutic responses with a panel of metabolic biomarkers in chronic myeloid leukemia patients.

Yang B, Wang C, Xie Y, Xu L, Wu X, Wu D. Yang B, et al. Among authors: wu x, wu d. Cancer Sci. 2018 Mar;109(3):777-784. doi: 10.1111/cas.13500. Epub 2018 Feb 14. Cancer Sci. 2018. PMID: 29316075 Free PMC article.

4

Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantation.

Wu X, Xie Y, Wang C, Han Y, Bao X, Ma S, Yilmaz A, Yang B, Ji Y, Xu J, Liu H, Chen S, Zhang J, Yu J, Wu D. Wu X, et al. Among authors: wu d. JCI Insight. 2018 May 3;3(9):e99672. doi: 10.1172/jci.insight.99672. JCI Insight. 2018. PMID: 29720575 Free PMC article.

5

Identification of metabolic biomarkers to predict treatment outcome and disease progression in multiple myeloma.

Zhao R, Xie Y, Yang B, Wang C, Huang Q, Han Y, Yang L, Yan S, Wang X, Fu C, Wu D, Wu X. Zhao R, et al. Among authors: wu x, wu d. Am J Cancer Res. 2020 Nov 1;10(11):3935-3946. eCollection 2020. Am J Cancer Res. 2020. PMID: 33294278 Free PMC article.

6

High stearic acid diet modulates gut microbiota and aggravates acute graft-versus-host disease.

Yang B, Zhang X, Gong H, Huang Y, Wang C, Liu H, Dong C, Ma S, Wu X, Wu D. Yang B, et al. Among authors: wu x, wu d. Signal Transduct Target Ther. 2021 Jul 23;6(1):277. doi: 10.1038/s41392-021-00600-9. Signal Transduct Target Ther. 2021. PMID: 34294684 Free PMC article. No abstract available.

7

Plasma Metabolomics Identifies the Dysregulated Metabolic Profile of Primary Immune Thrombocytopenia (ITP) Based on GC-MS.

Zhang Z, Wu X, Zhou M, Qi J, Zhang R, Li X, Wang C, Ruan C, Han Y. Zhang Z, et al. Among authors: wu x. Front Pharmacol. 2022 May 24;13:845275. doi: 10.3389/fphar.2022.845275. eCollection 2022. Front Pharmacol. 2022. PMID: 35685646 Free PMC article.

8

Low-dose emapalumab combined with chemotherapy for adult patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.

Zhu W, Zhou F, Song Y, Zhou S, Du F, Zhu Q, Wang Z, Bai L, Fu J, Ma X, Wu X, He X. Zhu W, et al. Among authors: wu x. Transpl Immunol. 2024 Dec 22:102162. doi: 10.1016/j.trim.2024.102162. Online ahead of print. Transpl Immunol. 2024. PMID: 39719162

9

[Preliminary exploration of the metabolic profile and metabolic pathways in newly diagnosed multiple myeloma].

Huang QL, Zhao RR, Yang BY, Jiang RY, Yang LL, Yan S, Fu ZZ, Wu DP, Wu XJ. Huang QL, et al. Among authors: wu xj, wu dp. Zhonghua Zhong Liu Za Zhi. 2022 Dec 23;44(12):1369-1375. doi: 10.3760/cma.j.cn112152-20201212-01066. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 36575789 Chinese.

10

Development of a scoring system for predicting primary resistance to venetoclax plus hypomethylating agents (HMAs) in acute myeloid leukemia patients.

Zong L, Yin M, Kong J, Zhang J, Song B, Zhu J, Xue S, Wu X, Wu D, Bao X, Qiu H. Zong L, et al. Among authors: wu x, wu d. Mol Carcinog. 2023 Oct;62(10):1572-1584. doi: 10.1002/mc.23600. Epub 2023 Aug 9. Mol Carcinog. 2023. PMID: 37555764 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59,305 results

Search Page

Filters